Oltipraz chemoprevention trial in Qidong, People's Republic of China: Unaltered oxidative biomarkers
- 1 September 2006
- journal article
- research article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 41 (6), 1010-1014
- https://doi.org/10.1016/j.freeradbiomed.2006.06.015
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (ES06052)
This publication has 36 references indexed in Scilit:
- Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltiprazCarcinogenesis: Integrative Cancer Research, 2003
- Aflatoxin and liver cancerBest Practice & Research Clinical Gastroenterology, 1999
- Isolation of cDNAs representing dithiolethione-responsive genesCarcinogenesis: Integrative Cancer Research, 1996
- Induction of hepatic heme oxygenase-1 and ferritin in rats by cancer chemopreventive dithiolethionesCarcinogenesis: Integrative Cancer Research, 1996
- Extreme exercise and oxidative DNA modificationJournal of Sports Sciences, 1996
- SHORT COMMUNICATION: Inhibition of aflatoxin M1 excretion in rat urine during dietary intervention with oltiprazCarcinogenesis: Integrative Cancer Research, 1996
- Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltiprazCarcinogenesis: Integrative Cancer Research, 1995
- Aflatoxin B1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNACarcinogenesis: Integrative Cancer Research, 1995
- Cancer Chemoprotection by Oltipraz: Experimental and Clinical ConsiderationsPreventive Medicine, 1993
- Oltipraz: A laboratory and clinical reviewJournal of Cellular Biochemistry, 1993